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ABSTRACT: A series of heteroleptic, neutral iridium(III)
complexes of the form [Ir(L)2(N^O)] (where L = cyclometalated
2,3-disubstituted quinoxaline and N^O = ancillary picolinate or
pyrazinoate) are described in terms of their synthesis and
spectroscopic properties, with supporting computational analyses
providing additional insight into the electronic properties. The 10
[Ir(L)2(N^O)] complexes were characterized using a range of
analytical techniques (including 1H, 13C, and 19F NMR and IR
spectroscopies and mass spectrometry). One of the examples was
structurally characterized using X-ray diﬀraction. The redox
properties were determined using cyclic voltammetry, and the
electronic properties were investigated using UV−vis, time-resolved luminescence, and transient absorption spectroscopies. The
complexes are phosphorescent in the red region of the visible spectrum (λem = 633−680 nm), with lifetimes typically of hundreds of
nanoseconds and quantum yields ca. 5% in aerated chloroform. A combination of spectroscopic and computational analyses suggests
that the long-wavelength absorption and emission properties of these complexes are strongly characterized by a combination of spin-
forbidden metal-to-ligand charge-transfer and quinoxaline-centered transitions. The emission wavelength in these complexes can
thus be controlled in two ways: ﬁrst, substitution of the cyclometalating quinoxaline ligand can perturb both the highest occupied
molecular orbital (HOMO) and lowest unoccupied molecular orbital levels (LUMO, Cl atoms on the ligand induce the largest
bathochromic shift), and second, the choice of the ancillary ligand can inﬂuence the HOMO energy (pyrazinoate stabilizes the
HOMO, inducing hypsochromic shifts).
■ INTRODUCTION
The development and study of luminescent cyclometalated
iridium(III) complexes continue to attract signiﬁcant atten-
tion.1 The motivation is driven by the use of such species in
optoelectronic applications such as bioimaging,2 electro-
luminescence,3 photoredox catalysis,4 nonlinear optics,5
chemosensing,6 and energy upconversion.7 Underpinning
these applications is the ability to control the physical
properties of the complex and, in particular, tuning8 of the
electronic properties that dictate the emission characteristics.
This can be achieved by the careful consideration and
combination of conjugated cyclometalated ligands and the
choice of the ancillary ligand.9 In this context, the vast majority
of Ir(III) complexes employ ﬁve-membered chelate ligands
(for example, 2-phenylpyridine), which result in either neutral
or cationic10 species. A handful of reports have also detailed
six-membered chelate systems, which can also have attractive
luminescence properties.11
The development of red-emissive Ir(III) complexes is very
attractive from a number of perspectives. First, interest in red
emitters has been driven by the advance of white-light-emitting
diodes, which require high-purity blue-, green-, and red-
emitting materials.12 The advantage of Ir(III) coordination
chemistry is that ligands can be developed to tune emission
across the visible-light spectrum, although the purity of the
emission colors can be compromised by the spectral broadness
of the emission bands. For this application, the development of
Ir(III) red phosphors is challenging because of the inherently
lower quantum eﬃciencies that result from a lower energy gap
between the ground and excited states. Red emitters are also
very attractive in bioimaging disciplines using confocal
ﬂuorescence microscopy;13 the use of longer excitation and
emission wavelengths tends to be more compatible with
biological samples, can signiﬁcantly improve imaging quality
through reduced autoﬂuorescence signals, and is complemen-
tary to the plethora of commercially available dyes.
A general strategy for bathochromically shifting the emission
wavelengths of Ir(III) complexes is to increase conjugation of
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the chelating ligands and introduce substituents for further
tuning. For example, exchanging 2-phenylpyridine for
1-phenylisoquinoline (i.e., comparing [Ir(ppy)3] vs [Ir(piq)3])
results in a red shift in the emission for the latter to around
620 nm.14 Researchers have further developed this strategy,15
including the use of various ancillary ligands.16 Indeed, a
number of reports have also shown that emission wavelengths
can be shifted further into the near-IR (>750 nm) region,
although quantum eﬃciencies are correspondingly lower.17
Our own contributions have focused upon the development of
substituted 2-phenylquinoline18 and 2-phenylquinoxaline19 as
cyclometalating ligands. Quinoxalines, in particular, provide an
adaptable ligand platform for developing red-emitting Ir(III)
complexes with good photostability.20
Herein, we report the development of a series of neutral,
mixed-ligand Ir(III) complexes (Scheme 1), where emission
wavelengths can be tuned 633 nm < λ < 680 nm by simple
variations in the cyclometalating quinoxaline ligand structure
and the choice of the ancillary ligand.21 A combination of
detailed spectroscopic and computational analyses have been
used to unravel the origins of the luminescence behavior and
fully ascribe the excited-state properties, providing a working
hypothesis for the rational design of complexes based on these
ligands.
■ RESULTS AND DISCUSSION
Synthesis of the Complexes. The tetrasubstituted
quinoxaline-based ligands (L1−L7), synthesized by the simple
condensation of an appropriate aryl diketone with a
disubstituted 1,2-phenylenediamine, were reported previous-
ly.7b From these ligands, a series of chloro-bridged Ir(III)
dimeric compounds of the formula [{Ir(L)2(μ-Cl)}2] were
synthesized according to the traditional method ﬁrst published
by Nonoyama.22 First, these dimeric Ir(III) species were then
reacted with picolinic acid to yield the corresponding charge-
neutral picolinate complexes [Ir(L)2(pic)] (where L = L1−L7;
Figure 1). This approach was also adopted in the isolation of
selected pyrazinoate variants (Figure 2), [Ir(L)2(pyz)] (where
L = L2, L5, and L7), with the exception of [Ir(L2)2(pyz)],
where improved yields were obtained via the bis(acetonitrile)
adduct cis-[Ir(MeCN)2(L2)2]BF4. Complete experimental and
synthetic details, as well as characterization data, are presented
in the Supporting Information.
Characterization of the Complexes. The complexes
synthesized in this study were characterized by a range of
techniques including 1H, 13C{1H}, and 19F{1H} NMR
spectroscopy, in addition to high-resolution mass spectrome-
try. All of the complexes showed good solubility in common
organic solvents such as chloroform, acetonitrile, methanol,
and acetone.
Inclusion of the asymmetric picolinate or pyrazinoate ligand
in the coordination sphere renders the two cyclometalated
quinoxaline ligands inequivalent. This increases the complexity
of the resulting NMR spectra of these species. For example, the
Scheme 1. General Molecular Structure of the Complexes
under Investigation
Figure 1. Structures of the mixed-ligand iridium(III) picolinate complexes [Ir(L)2(pic)].
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1H NMR spectrum of [Ir(L1)2(pic)] showed two unique
methyl environments at ca. 3.35 ppm, as well as unique
resonances for each of the quinoxaline-based protons. The lack
of symmetry in these complexes is apparent in comparison to
the spectra for the previously reported [Ir(L1)2(bipy)]PF6,
wherein the cyclometalating ligands are equivalent (Figure
S1).7b Other general features in the 1H NMR spectra include
two upﬁeld doublets at ca. 6−7 ppm, which correspond to the
protons ortho to the cyclometalating C atom on each unique
quinoxaline ligand. In the majority of cases, the 13C{1H} NMR
spectra revealed a furthest downﬁeld resonance of ca. 170 ppm,
which was assigned to the carbonyl group of the coordinated
picolinate or pyrazinoate ligand. The ﬂuorine-containing
complexes were also analyzed via 19F{1H} NMR spectroscopy,
and the data are presented in Table 1 alongside those of
relevant free ligands.
Figure 2. Structures of the mixed-ligand iridium(III) pyrazinoate complexes [Ir(L)2(pyz)].
Table 1. Comparison of the 19F{1H} NMR Data for the
Fluorinated Ligands and Complexes
compound δF (ppm)
L4a −130.4 (d, 21 Hz), −131.2 (d, 21 Hz)
L7a −129.9
[Ir(L4)2(pic)]
b −131.8 (d, 21 Hz), −132.9 (d, 21 Hz), −133.7 (d, 19
Hz), −134.0 (d, 19 Hz)
[Ir(L7)2(pic)]
b −130.2 (d, 19 Hz), −131.5 (d, 19 Hz), −133.1 (d, 21
Hz), −133.6 (d, 22 Hz)
[Ir(L7)2(pyz)]
a −123.5 (d, 22 Hz), −128.1 (d, 22 Hz), −128.5 (d, 22
Hz), −130.5 (d, 22 Hz)
aCDCl3.
bCD3CN.
Figure 3. X-ray structure of [Ir(L7)2(pic)]: C49H32F4IrN5O3, Mr = 1006.99, triclinic, P1̅ (No. 2), a = 11.4642(3) Å, b = 12.2735(2) Å, c =
14.3213(3) Å, α = 76.139(2)°, β = 86.773(2)°, γ = 88.029(2)°, V = 1952.85(7) Å3, T = 100(2) K, Z = 2, Z′ = 1, μ(Cu Kα) = 7.230 mm−1, 51782
reﬂections measured, 7115 unique (Rint = 0.0887), which were used in all calculations. The ﬁnal wR2 was 0.1050 (all data), and R1 was 0.0411 [I >
2(I)]. Inset: Packing diagram for [Ir(L7)2(pic)]. Ellipsoids drawn at 50%.
Table 2. Selected Bond Lengths (Å) and Bond Angles (deg)
from the Crystallographic Data of [Ir(L7)2(pic)]
Bond Lengths (Å)
Ir1−O41 2.156(4) Ir1−N41 2.195(4)
Ir1−N1 2.055(4) Ir1−C1 1.980(6)
Ir1−N21 2.066(4) Ir1−C21 1.981(6)
Bond Angles (deg)
O41−Ir1−N41 76.10(15) C1−Ir1−N21 96.8(2)
N1−Ir1−O41 81.47(15) C1−Ir1−N41 166.5(2)
N1−Ir1−N21 175.58(16) C1−Ir1−C21 93.3(2)
N1−Ir1−N41 98.55(16) C21−Ir1−O41 176.21(16)
N21−Ir1−O41 101.02(15) C21−Ir1−N1 98.61(19)
N21−Ir1−N41 85.63(16) C21−Ir1−N21 79.15(19)
C1−Ir1−O41 90.41(18) C21−Ir1−N41 100.17(19)
C1−Ir1−N1 79.5(2)
Inorganic Chemistry pubs.acs.org/IC Article
https://dx.doi.org/10.1021/acs.inorgchem.9b02991
Inorg. Chem. 2020, 59, 2266−2277
2268
Because of the inequivalence of the cyclometalating ligands,
four 19F resonances, which appear in the −120 to −140 ppm
range, were observed in the 19F{1H} NMR spectra for the
ﬂuorinated complexes, and thus are consistent with the
[Ir(L)2(bipy)]PF6 analogues. Each resonance appeared as a
doublet arising from 3JFF coupling at ca. 19−22 Hz. The 19F
resonances of the picolinate species were subtly shifted upﬁeld
from the free ligands, whereas for the pyrazinoate species, the
resonances were generally downﬁeld. This suggests that the
relative donor characteristics of the ancillary ligand can
inﬂuence the electron density at Ir(III) and thus modulate
the electronic environment of the ﬂuorine substituents on the
cyclometalated quinoxaline ligands. The 19F{1H} NMR data
support the notion that picolinate is a stronger donor to Ir(III)
than pyrazinoate.
All complexes in this study were also characterized by high-
resolution mass spectrometry. In each case, a molecular-ion
peak was present and consistent with the expected isotopic
distribution for a protonated parent ion, [M + H]+, or a
sodium ion adduct, [M + Na]+. In some cases, a fragment was
also present that contained both cyclometalating ligands but
with a loss of the ancillary ligand (Figure S2).
X-ray Crystallography Structure. Single red plate-shaped
crystals of [Ir(L7)2(pic)] were successfully isolated, from the
slow evaporation of an acetone solution of the complex, and
then investigated using X-ray diﬀraction.23 Data collection
parameters are in the caption of Figure 3; see Table 2 for
selected bond lengths and bond angles. The structure reveals
that the complex crystallized as its acetone solvate, with one
molecule of acetone per complex moiety.
The structure conﬁrms the expected coordination sphere at
Ir, with the quinoxaline-derived ligands coordinating in a
cyclometalating mode, resulting in a cis-C,C and trans-N,N
coordination arrangement at Ir(III). The coordinated
picolinate ligand is bound to Ir(III) via the N^O chelating
mode. The bond lengths within the coordination sphere are
closely comparable to those of related complexes that
incorporate cyclometalated phenylquinoxaline ligands.7b The
structure also reveals intermolecular packing supported by π−π
interactions of ca. 3.65 Å (Figure 3, inset) that involve the
diﬂuorinated quinoxaline ring.
Table 3. UV−Vis Absorption and Redox Properties of the
Complexes
cyclic voltammetrya
complex
UV−vis absorptionb λmax
(nm) Eox (V) Ered (V)
[Ir(L1)2(pic)] 274 sh, 364 sh, 373, 491 sh +1.16 −1.42
[Ir(L2)2(pic)] 276, 381, 507 sh +1.11 −1.51
[Ir(L3)2(pic)] 273, 300, 371, 389, 538 sh +1.27 −1.17
[Ir(L4)2(pic)] 272, 361, 377, 501 sh +1.26 −1.05, −1.27
[Ir(L5)2(pic)] 262, 300, 387, 501 sh +1.09 −1.25
[Ir(L6)2(pic)] 273, 396, 528 sh +1.31 −1.12
[Ir(L7)2(pic)] 277, 387, 505 sh +1.30 −1.24
[Ir(L2)2(pyz)] 267, 380, 480 sh +1.18 −0.98, −1.35
[Ir(L5)2(pyz)] 271, 386, 489 sh +1.19 −1.04, −1.42
[Ir(L7)2(pyz)] 272, 383, 494 sh +1.39 −1.00, −1.15
aThe oxidation potentials were measured as dichloromethane
solutions at 200 mV s−1 with 0.1 M [NBu4][PF6] as the supporting
electrolyte calibrated with Fc/Fc+ at +0.46 V. bChloroform solutions,
10−5 M.
Figure 4. Left: UV−vis absorption spectra recorded for the picolinate complexes. Right: UV−vis absorption spectra recorded for the pyrazinoate
complexes. All samples were recorded in chloroform at 10−5 M.
Figure 5. UV−vis absorption spectra showing the inﬂuence of the
ancillary ligand (picolinate vs pyrazinoate vs bipyridine) across Ir(III)
complexes of L2.
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Electrochemical Properties of the Complexes. The
electrochemical characteristics of the Ir(III) complexes were
investigated in deoxygenated dichloromethane. Cyclic voltam-
mograms were measured using a platinum disk electrode (scan
rate 200 mV s−1; 1 × 10−3 M solutions; 0.1 M [NBu4][PF6] as
the supporting electrolyte). In most cases, the complexes each
showed one oxidative and one reductive process (Table 3).
The oxidation process appeared in the range of +1.1 to +1.4 V
and was attributed, and found to be generally irreversible, to
the Ir3+/4+ couple. These oxidative values are lower than those
for the corresponding cationic species [Ir(L)2(bipy)]PF6,
which is consistent with an Ir3+ center that is more easily
oxidized in these neutral species. Within the series of
complexes, the substituents of the quinoxaline cyclometalating
ligand have a signiﬁcant inﬂuence on the redox potentials: the
halogenated complexes have higher oxidation potentials,
whereas the methylated variants are most easily oxidized.
These observations are again consistent with the relative
electron-donating capacity of the coordinated quinoxaline
ligands. The ancillary ligand also has a subtle inﬂuence on the
Ir3+/4+ couple, with the pyrazinoate species possessing a more
positive oxidation potential than their picolinate counterparts,
again consistent with the relative electron-donating capacity of
the two ligands. The observed reduction features, most of
which were irreversible, are assumed to be ligand-based
processes,7b with the pyrazinoate complexes introducing a
feature around −1 V.
UV−Vis Absorption Properties of the Complexes. The
UV−vis absorption spectra of all complexes were recorded as
solutions in chloroform at a concentration of 10−5 M. Figure 4
shows the spectra recorded for each series. In both sets of
spectra, three distinct features can be seen: a peak at around
275−300 nm from ligand-based π−π* transitions, a feature at
Figure 6. Left: Comparison of the experimental (red) and simulated (black) absorption spectra for [Ir(L1)2(pic)]. In the left-hand panel, the
computed spectrum is constructed by convolution of the TD-DFT transition energies and their associated oscillator strengths. The spin-forbidden
peak at λ > 500 nm is shown for reference, with an arbitrary oscillator strength scaled as a guide to the eye. The simulated spectrum is comprised of
singlet and triplet transitions from the singlet ground state. Right: Comparison of the observed spectra of [Ir(L1)2(pic)] (black) and
[Ir(L1)2(bipy)]PF6 (red).
Table 4. Computed Values for the Absorption and Emission
Maxima of the Ir(III) Complexesa
complex S0 → S1 (nm) S0 → T1 (nm) T1 → S0 (nm)
[Ir(L1)2(pic)] 424 578 697 (6467)
[Ir(L2)2(pic)] 419 568 689 (640)
[Ir(L3)2(pic)] 440 608 739 (665)
[Ir(L4)2(pic)] 428 586 710 (650)
[Ir(L5)2(pic)] 425 579 705 (648)
[Ir(L6)2(pic)] 445 618 751 (680)
[Ir(L7)2(pic)] 434 597 722 (653)
[Ir(L2)2(pyz)] 416 563 685 (633)
[Ir(L5)2(pyz)] 422 573 703 (641)
[Ir(L7)2(pyz)] 431 589 714 (651)
aExperimentally determined T1 → S0 values are presented in
parentheses.
Table 5. Summary of the Major Calculated Contributions to Each Molecular Orbital from Each Part of the Complexa
Ir 5d Q1 Q2 pic/pyz
complex HOMO−1 HOMO LUMO LUMO+1 LUMO LUMO+1 LUMO+2
[Ir(L1)2(pic)] 43 40 36 59 59 36 96
[Ir(L2)2(pic)] 37 39 34 60 60 34 96
[Ir(L3)2(pic)] 41 39 40 55 55 40 94
[Ir(L4)2(pic)] 40 39 39 56 56 39 96
[Ir(L5)2(pic)] 21 38 38 57 57 38 94
[Ir(L6)2(pic)] 21 38 42 53 53 41 6
[Ir(L7)2(pic)] 16 38 41 54 54 41 90
[Ir(L2)2(pyz)] 28 38 48 47 38 39 77
[Ir(L5)2(pyz)] 10 37 41 35 47 48 76
[Ir(L7)2(pyz)] 8 37 44 46 49 46 89
aQ1 and Q2 are the inequivalent quinoxaline ligands.
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ca. 375 nm with a shoulder around 430 nm, and a broader
feature around 500 nm that tails >600 nm. In the context of
previous reports, both ligand-based π−π* transitions from the
conjugated quinoxalines and spin-allowed metal-to-ligand
charge-transfer (MLCT) transitions are likely to contribute
to the features at 350−450 nm. Similarly, spin-forbidden
transitions, mediated by the heavy Ir atom, to the 3MLCT state
are likely to contribute to the weaker feature (typical ε ≈
103 M−1 cm−1) that dictates the 500−600 nm region of the
spectra.
Within the series of picolinate complexes [Ir(L)2(pic)],
variations in the energies of the MLCT features are dictated by
the nature of the substituents on the quinoxaline ligands.
Similarly, the pyrazinoate complexes [Ir(L)2(pyz)] show the
same principle features in their absorption spectra. A direct
comparison between [Ir(L2)2(pic)] and [Ir(L2)2(pyz)] shows
that the latter possesses subtly, hypsochromically shifted
MLCT features. Compared to the previously reported cationic
variant [Ir(L2)2(bipy)]PF6, both neutral analogues display a
bathochromically shifted 3MLCT feature (Figures 5 and S3−
S8).7b
Density Functional Theory (DFT). DFT calculations,
performed on each complex discussed herein, support the
assignments of the features in the absorption spectra through
time-dependent DFT (TD-DFT). Qualitatively, the simulated
absorption spectra (e.g., Figures 6 and S9−S17) are in
reasonable agreement with the experimental absorption
spectra, each with three main components in the same relative
order of intensity as that of the absorption spectra, although
the DFT procedure underestimates the absolute energy of all
transitions (Table 4). The absorption bands of <450 nm are
predominantly 1MLCT in character because the occupied
molecular orbitals involved in the excitation generally carry
signiﬁcant metal contributions (25−38%), while the unoccu-
pied molecular orbitals are predominantly localized on the
quinoxaline ligands. The calculations also predict that
unoccupied molecular orbitals localized on either the
picolinate or pyrazinoate ancillary ligands do not contribute
Figure 7. Examples of calculated Kohn−Sham molecular orbitals for [Ir(L1)2(pic)]. Similar representations for all other complexes in the series are
available in the Supporting Information.
Table 6. Description of the Calculated Molecular Orbital
Contributions, Excited-State Descriptions, and Their
Associated Transitions for [Ir(L1)2(pic)] (pic =
Picolinate)a
moiety contributions to
the orbital (%)
orbital contributions to the excited
states
orbital
Ir
5d pic Q1 Q2 excited state
contributing
transitions
LUMO+4 1 1 78 21 1 (423.97 nm;
f = 0.0349)
HOMO →
LUMO (87%)
LUMO+3 1 23 15 62 2 (415 nm; f =
0.1237)
HOMO →
LUMO+1
(84%)
LUMO+2 2 96 2 0
LUMO+1 4 1 59 36 3 (343.01 nm;
f = 0.089)
HOMO−2 →
LUMO (37%)
LUMO 4 1 36 59 HOMO−1 →
LUMO (43%)
HOMO 40 4 29 27 4 (329.34 nm;
f = 0.0442)
HOMO−1 →
LUMO+1
(21%)
HOMO−1 43 14 23 20 HOMO−1 →
LUMO+1
(48%)
HOMO−2 9 8 51 32 5 (321.19 nm;
f = 0.1511)
HOMO−3 →
LUMO (38%)
HOMO−3 34 5 14 47 HOMO−2 →
LUMO+1
(15%)
HOMO−4 14 19 54 13
aQ1 and Q2 are the diﬀerent quinoxaline ligands.
Table 7. Calculated Energies of the Frontier Orbitals of the
Ir(III) Complexes and Their Diﬀerences, Ordered by
Decreasing ΔE
complex HOMO (eV) LUMO (eV) ΔE (eV)
[Ir(L2)2(pyz)] −5.43 −2.41 3.02
[Ir(L2)2(pic)] −5.33 −2.32 3.01
[Ir(L5)2(pyz)] −5.44 −2.46 2.98
[Ir(L1)2(pic)] −5.42 −2.45 2.97
[Ir(L5)2(pic)] −5.34 −2.38 2.96
[Ir(L7)2(pyz)] −5.63 −2.73 2.9
[Ir(L4)2(pic)] −5.53 −2.6 2.93
[Ir(L7)2(pic)] −5.53 −2.65 2.88
[Ir(L3)2(pic)] −5.6 −2.75 2.85
[Ir(L6)2(pic)] −5.61 −2.79 2.82
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to the lowest unoccupied molecular orbital (LUMO) or
LUMO+1 but rather dominate LUMO+2 (Tables 4 and 5).
The simulated spectra all show a longest wavelength feature
between 560 and 620 nm, which is predicted to be the spin-
forbidden 3MLCT (i.e., S0 → T1) transition, which again
corresponds to the low-intensity shoulder present in the
experimentally obtained spectra of the complexes. Compre-
hensive details for each complex are presented in the
Supporting Information.
Again, it is useful to compare these systems against their
cationic complex analogues, [Ir(L)2(bipy)]PF6.
7b In those
systems, the complexes exhibited C2 symmetry, and the two
coordinated quinoxaline ligands were eﬀectively degenerate,
with equal contributions from each to the frontier orbitals,
suggesting signiﬁcant delocalization. Moving from a bipyridine
ancillary ligand to the picolinate/pyrazinoate complexes
reported herein removes this delocalization, breaking the
symmetry of the system and splitting the orbital contributions
of the quinoxalines.
The molecular orbitals within the picolinate complexes
(Figures 7 and S18−S23) now form pseudodegenerate pairs
with alternating contributions from each of the quinoxalines:
e.g., the [Ir(L1)2(pic)] LUMO is made up of contributions of
36% and 59% (Table 6) from the quinoxalines Q1 and Q2,
respectively, while the LUMO+1 shows the reverse (Q1 =
59%; Q2 = 36%). This eﬀect is presumably due to diﬀering
interactions of the two quinoxalines with the asymmetric
ancillary ligand. Notably, the pyrazinoate complexes do not
show these pseudodegenerate pairs but, nonetheless, show a
loss of degeneracy between the quinoxaline ligands, with
greater contributions from one quinoxaline than the other.
This eﬀect likely contributes to the weak structure observed in
the experimental absorption spectra of 300 nm < λ < 400 nm.
The TD-DFT calculations also suggest that there are no singlet
transitions (Table 6) at wavelengths long enough to account
for the absorption at λ > 500 nm, whereas the lowest-energy
singlet-to-triplet transition is within the 550 nm < λ < 620 nm
region for all complexes. This is consistent with the
observation of the long-wavelength, low-intensity absorption
shoulder band observed in the experimental data (Figure 6).
Figures S18−S26 and Tables S1−S9 contain the molecular
orbital decomposition analyses for [Ir(L)2(pic)] (L = L2−L7)
and [Ir(L)2(pyz)] (L = L2, L5, and L7).
Singlet and triplet geometries were calculated for each of the
complexes along with stationary point-energy estimations of
each spin state from the other geometry, allowing vertical
transitions to be calculated. This was performed with the goal
of simulating the spin-forbidden absorption and emission
bands using approximations of the purely electronic
component of the transition, without the geometric energy
contributions associated with changing between the two
diﬀerent spin states. However, the calculated spin-forbidden
absorption and emission bands signiﬁcantly underestimate the
energies involved; for example, the emission maximum for
[Ir(L2)2(pic)] is experimentally observed at 640 nm (see the
later discussion), yet the calculated T1 → S0 vertical transition
value was 689 nm. Therefore, this method can be considered
as giving a good qualitative rather than quantitative insight into
the eﬀect that ligand structure alterations will have on the
complex’s spectral properties because the ordering of the
complex emission centers is correct despite the energetic oﬀset.
The predicted eﬀects of quinoxaline ligand substitution were
investigated by examining the energy values of the HOMO and
LUMO for each of the complexes (Table 7). Electron-
withdrawing groups are known to have a stabilizing eﬀect on
the metal-dominated HOMO through removal of the electron
density, while electron-donating groups have the inverse
eﬀect.24 Here, those complexes possessing quinoxaline ligands
with electron-withdrawing groups (e.g., F, Cl) exhibit lower-
energy values for the frontier orbitals. The LUMO is typically
stabilized more eﬀectively than the HOMO, a feature that can
Figure 8. Emission spectra obtained for the picolinate complexes [Ir(L)2(pic)] (left) and the pyrazinoate complexes [Ir(L)2(pyz)] (right).
Table 8. Experimentally Determined Photophysical
Properties of the Complexesa
complex
λem
(nm)b τobs (ns)
c
ϕ
(%)d
knr
(×106)
kr
(×105)
[Ir(L1)2(pic)] 647 303.9 ± 0.1 4.1 3.2 1.3
[Ir(L2)2(pic)] 640 285.6 ± 0.5 6.8 3.3 2.4
[Ir(L3)2(pic)] 665 266.3 ± 0.1 3.6 3.6 1.4
[Ir(L4)2(pic)] 650 289 ± 0.1 4.8 3.3 1.7
[Ir(L5)2(pic)] 648 306.0 ± 0.2 3.2 3.1 1.0
[Ir(L6)2(pic)] 680 285.0 ± 0.5 2.7 3.4 0.9
[Ir(L7)2(pic)] 653 290.4 ± 0.1 4.8 3.3 1.7
[Ir(L2)2(pyz)] 633 351.0 ± 0.9 5.9 2.7 1.7
[Ir(L5)2(pyz)] 641 328.2 ± 0.1 2.9 3.0 0.9
[Ir(L7)2(pyz)] 651 352.0 ± 0.1 1.3 2.8 0.4
aAerated chloroform solutions. bEmission wavelength; λexc = 355 nm.
cObserved lifetime. dQuantum yield.
Inorganic Chemistry pubs.acs.org/IC Article
https://dx.doi.org/10.1021/acs.inorgchem.9b02991
Inorg. Chem. 2020, 59, 2266−2277
2272
be ascribed to the greater involvement of the quinoxaline
ligands in the LUMO and thus a more pronounced eﬀect as
the electron aﬃnity of the ligand is increased. This disparity
between the eﬀect on each orbital gives rise to slight
diﬀerences in the emission and absorption energies observed
for the complexes because the HOMO-to-LUMO gap is
reduced for those with electron-withdrawing groups and
increased for those with electron-donating groups (e.g.,
methyl), relative to the unsubstituted complex [Ir(L1)2(pic)].
The phenyl-substituted complexes exhibit HOMO energy
values very similar to those of their methylated counterparts
but show lower LUMO values.
The eﬀect of the ancillary ligand is somewhat similar:
varying the ligand stabilizes or destabilizes the frontier orbitals
of the complex by removing or increasing electron density on
the metal center. In this case, both ligand types (picolinate and
pyrazinoate) are relatively electron-withdrawing, and the eﬀect
is more pronounced for the pyrazinoates because of the
presence of an additional N in the ring. Although electron
withdrawal stabilizes the HOMO and LUMO, the relative
stabilization is not identical with the eﬀect of quinoxaline
substitution. In this instance, the calculated energies of the
molecular orbitals suggest that the pyrazinoate complexes have
HOMO (0.1 eV) levels that are stabilized slightly more than
the LUMO (∼0.09 eV) compared to their picolinate
counterparts. This eﬀect gives rise to a predicted slight
hypsochromic shift in the pyrazinoate complexes. The changes
in the HOMO versus LUMO stabilization may be readily
explained by the larger metal contribution to the HOMO. It is
worth noting that the similarity in the band proﬁle of the
emission spectra regardless of the ancillary ligand, along with
the almost identical nature of the long-wavelength 1MLCT
absorption bands displayed in Figure 5, illustrate that, although
the ancillary ligand may tune the positions of the HOMO and
LUMO orbitals, it does not signiﬁcantly contribute to them or
change their overall electronic character. This is consistent
with the orbital decomposition analysis presented above.
Luminescence Properties of the Complexes. Emission
spectra were obtained on each of the complexes using aerated
chloroform and an excitation wavelength of 355 nm (Figure 8).
Each of the neutral complexes was emissive in the red region of
the spectrum between 633 and 680 nm, with quantum yields
(ϕ) typically of ca. 5% (Table 8). All emission peaks appear as
featureless broad bands. Observed emission lifetimes (τobs)
were obtained from time-resolved data ﬁtted to a mono-
exponential function. The values for the rates of nonradiative
(knr) and radiative (kr) decays were calculated from the
experimental data and show that knr ≫ kr in all cases. The kr
values are indicative of a signiﬁcant spin−orbit coupling
(SOC) contribution but slightly lower than that reported for
fac-[Ir(ppy)3], 4 × 10
5 s−1.25
Compared to the corresponding cationic complexes [Ir-
(L)2(bipy)]PF6, the current series of compounds demonstrate
bathochromically shifted emission maxima for a given
quinoxaline ligand (Figure 8). As noted earlier, the trend
across the series of complexes in the experimental emission
maxima is quite well replicated using the computational
methods discussed earlier. For example, [Ir(L2)2(pyz)], which
was calculated to possess the largest HOMO−LUMO energy
gap, also displayed the shortest-wavelength emission band. A
comparison of the emission data for [Ir(L2)2(pic)] and
[Ir(L2)2(pyz)] shows that the latter is indeed hypsochromi-
cally shifted. However, the cyclic voltammetry data showed
that [Ir(L2)2(pyz)] possesses the smallest electrochemical
band gap in the series of complexes. For a pure 3MLCT
Figure 9. Left: Example of a TA spectrum using [Ir(L1)2(pic)]. The gray horizontal line corresponds to a ΔOD value of zero, such that negative-
trajectory features correspond to the depletion of a ground-state absorption and positive features correspond to excited-state absorption. Right:
Kinetic traces of the major features of [Ir(L1)2(pic)]. The top trace is an emission trace, and the bottom ﬁve are diﬀerence optical density
measurements. All traces are ﬁtted to monoexponential functions, and the obtained lifetimes are displayed alongside. Similar representations for all
other complexes in the series are available in the Supporting Information.
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emitter, a decrease in the electrochemical band gap would be
expected to manifest in a bathochromic shift in λem.
26
In the cases of [Ir(L2)2(pic)] and [Ir(L2)2(pyz)], additional
deoxygenated luminescence lifetimes show modest increases to
1.283 and 1.883 μs, respectively. The magnitudes of these
lifetimes are consistent with the reduction in 3O2 collisional
quenching, aﬀording the deﬁnitive assignment that the
emissive state is triplet in character. A comparison of the
77 K emission spectra (Figure S27) for [Ir(L2)2(pic)] and
[Ir(L2)2(pyz)] (as 1:3 methanol/ethanol frozen glasses) shows
emission proﬁles with a little vibronic deﬁnition and a slight
hypsochromic shift to λem = 627 and 617 nm, respectively,
which can be attributed to the rigidochromic eﬀect of the
frozen medium. Further, solvatochromic luminescence studies
were conducted on [Ir(L2)2(pyz)] using a range of diﬀerent
solvents. The resultant data in toluene (λem = 622 nm),
dichloromethane (626 nm), acetonitrile (632 nm), and
dimethyl sulfoxide (636 nm) show a subtle bathochromic
shift with increasing solvent polarity. Taken together, these
observations suggest that some 3MLCT character is likely to
contribute to the emitting states of these complexes, as implied
by the supporting DFT calculations.
Transient Absorption (TA) Spectra and Kinetics. TA
spectra of the Ir(III) complexes showed three distinct features
(Figures 9 and S28−S36). The ﬁrst, ca. 350 < λ < 400 nm, is
ascribed to a ground-state bleach: depletion of the ground-
state 1MLCT absorption band was seen in this region for all
complexes. The second TA band is a strong positive-going
feature in the 400 nm < λ < 500 nm region, with two peaks
discernible in most of the spectra. These are assigned as triplet-
to-triplet transitions because the lifetimes (Table 8) of the
features correspond closely to those of the T1 → S0 emission
decay kinetics of the complexes (Figures 9 and S37−S45).
Assignments of these features as photophysics arising from
triplet-state manifolds were conﬁrmed by extension of all
observed transient lifetimes in the absence of O2 (using
[Ir(L2)2(pic)] and [Ir(L2)2(pyz)] as examples), consistent
with rapid intersystem crossing occurring within the instru-
ment response function (subnanosecond; Table 9).
TD-DFT calculations, performed at the triplet-state
minimum-energy geometry, are also in agreement with this
assignment, suggesting that there are a set of spin-allowed
transitions within this wavelength region. Also visible in the TA
Table 9. Time-Resolved TA Properties of the Complexes
complex ground-state bleach excited-state absorption
[Ir(L1)2(pic)]
a 375 nm (341.9 ± 7.9 ns) 397 nm (268.4 ± 3.0 ns)
428 nm (279.3 ± 1.1 ns)
454 nm (290.8 ± 0.5 ns)
617 nm (324.2 ± 1.7 ns)
[Ir(L2)2(pic)]
a 375 nm (332.3 ± 5.8 ns) 400 nm (304.6 ± 4.8 ns)
410 nm (301.5 ± 2.0 ns)
460 nm (320.9 ± 2.2 ns)
600 nm (350.0 ± 2.0 ns)
[Ir(L3)2(pic)]
a 368 nm (262.7 ± 3.8 ns) 410 nm (253.6 ± 0.7 ns)
383 nm (245.7 ± 3.6 ns) 460 nm (274.1 ± 0.3 ns)
649 nm(275.3 ± 2.3 ns)
[Ir(L4)2(pic)]
a 375 nm (264.8 ± 7.3 ns) 402 nm (270.4 ± 0.9 ns)
430 nm (260.2 ± 0.3 ns)
450 nm (252.9 ± 0.3 ns)
628 nm (304.6 ± 2.5 ns)
[Ir(L5)2(pic)]
a 375 nm (324.7 ± 7.9 ns) 433 nm (326.3 ± 0.5 ns)
455 nm (336.6 ± 0.9 ns)
610 nm (328.9 ± 3.1 ns)
[Ir(L6)2(pic)]
a 375 nm (292.4 ± 4.6 ns) 440 nm (297.5 ± 0.5 ns)
470 nm (296.5 ± 0.4 ns)
[Ir(L7)2(pic)]
a 375 nm (240.8 ± 4.0 ns) 430 nm (280.6 ± 0.4 ns)
460 nm (268.1 ± 0.4 ns)
[Ir(L2)2(pyz)]
a 372 nm (392.8 ± 15.2 ns) 419 nm (343.0 ± 3.9 ns)
454 nm (382.2 ± 4.1 ns)
585 nm (372.1 ± 2.9 ns)
[Ir(L5)2(pyz)]
a 370 nm (328.8 ± 4.0 ns) 431 nm (349.1 ± 1.7 ns)
459 nm (360.8 ± 1.3 ns)
604 nm (380.0 ± 1.1 ns)
[Ir(L7)2(pyz)]
a 355 nm (341.98 ± 4.6 ns) 440 nm (342.1 ± 0.8 ns)
550 nm (395.2 ± 2.1 ns)
[Ir(L2)2(pic)]
b 375 nm (1450 ± 24 ns) 400 nm (1345 ± 26 ns)
410 nm (1284 ± 11 ns)
460 nm (1285 ± 5 ns)
600 nm (1267 ± 11 ns)
[Ir(L2)2(pyz)]
b 372 nm (2159 ± 200 ns) 419 nm (1954 ± 40 ns)
454 nm (1914 ± 33 ns)
585 nm (1836 ± 34 ns)
aAerated solutions in chloroform. bDeaerated solutions in chloro-
form.
Figure 10. Comparison of the TA spectra of the picolinate (left) and pyrazinoate (right) Ir(III) complexes. The gray arrows highlight the spectral
shifts described in the main text.
Inorganic Chemistry pubs.acs.org/IC Article
https://dx.doi.org/10.1021/acs.inorgchem.9b02991
Inorg. Chem. 2020, 59, 2266−2277
2274
spectra is a broad, but weak, positive-going signal, centered at
ca. λ = 600 nm. This was also assigned to a triplet-to-triplet
absorption.
The structured absorption proﬁles in the region 400 nm < λ
< 500 nm (notably in Figure 9) are ascribed to the
pseudodegeneracy of the LUMO noted in the Density
Functional Theory (DFT) section, resulting in numerous
absorption features very close to each other in energy. This can
be observed faintly in the ground-state absorption spectra of
some of the complexes but is far more prominent in the TA
spectra, highlighting the sensitivity of this technique as a means
of characterization. Importantly, this structure to the
absorption feature was not visible in the cationic variants
[Ir(L)2(bipy)]PF6.
7b As with the emission spectra, the TA
spectra display a band shift (Figure 10) relative to [Ir-
(L1)2(pic)] depending on the ligand type. All of the picolinate
complexes exhibit TA spectra that are bathochromically shifted
relative to the [Ir(L1)2(pic)] complex. The magnitude of this
shift depends on the quinoxaline ligand substitution, with
phenyl-substituted ligands inducing a greater shift than simple
halogenation at the quinoxaline ring (Table 9). It is
noteworthy that very few examples of the TA spectra of
organometallic complexes have been reported in the
literature.27
■ CONCLUSIONS
In summary, this study has shown that heteroleptic neutral
iridium(III) complexes, [Ir(L)2(N^O)] (where N^O =
picolinate or pyrazinoate), incorporating cyclometalated
quinoxaline ligands can demonstrate tunable emission in the
long-wavelength part of the visible spectrum. The emission
from these complexes likely arises from a mixture of
quinoxaline-centered and 3MLCT excited states. A combina-
tion of spectroscopic, electrochemical, and computational
analyses lends support to the assignment and sheds light on
the origin of the tunable nature of the emission. Crucially this
insight shows that two strategies are available for modulating
the emission energies of the complexes. First, substitution of
the quinoxaline ligands inﬂuences both the HOMO and
LUMO levels. Second, the ancillary picolinate or pyrazinoate
ligands can modulate the HOMO level of the complex but are
unlikely to contribute to any of the excited states that are
relevant to the luminescence character. This ﬁnal point is
noteworthy because previous work28 has suggested that the
triplet excited-state level of related N^O ligands must be
considered alongside any MLCT characteristics. Given the
ease of functionalization of these complexes, our future studies
will explore the application of these Ir(III) species in
bioimaging studies, which can exploit the tuneability of long-
wavelength luminescence properties.
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